Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Vista Gold And 2 Other Stocks Under $2 Insiders Are Buying

Author: Avi Kapoor | March 22, 2024 08:58am

The Dow Jones index closed higher by over 250 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Vista Gold

  • The Trade: Vista Gold Corp. (NYSE:VGZ) CFO Douglas L. Tobler acquired a total of 3,500 shares an average price of $0.48. To acquire these shares, it cost around $1,691.
  • What’s Happening: On March 14, Vista Gold posted a fourth-quarter loss of 1 cent per share.
  • What Vista Gold Does: Vista Gold Corp is a gold mining company. It is engaged in the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects.

Retractable Technologies

  • The Trade: Retractable Technologies, Inc. (NYSE:RVP) President and CEO Thomas J Shaw acquired a total of 2,147 shares at at an average price of $1.19. To acquire these shares, it cost around $2,555.
  • What’s Happening: On Nov. 14, Retractable Technologies reported that its loss from operations was $8.7 million for the first nine months of 2023.
  • What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.

Check This Out: Top 3 Tech And Telecom Stocks That Are Ticking Portfolio Bombs

Fresh Tracks Therapeutics

  • The Trade: Fresh Tracks Therapeutics, Inc. (OTC:FRTX) 10% owner Exploration Capital, LLC acquired a total of 297 shares at an average price of $0.91. The insider spent around $270 to buy those shares.
  • What’s Happening: The company’s stock fell around 6% over the past six months.
  • What Fresh Tracks Therapeutics Does: Fresh Tracks Therapeutics Inc does not have any operations as it has discontinued its activities.

 

Don’t forget to check out our premarket coverage here

 

Posted In: FRTX RVP VGZ

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist